Weill Cornell Infectious Diseases Division (@wcm_id) 's Twitter Profile
Weill Cornell Infectious Diseases Division

@wcm_id

Official account of @WeillCornell's Division of Infectious Diseases and Fellowship Training Program. Tweets by @rk3 & @msimon6720 #IDTwitter #IDMedEd #WeAreID

ID: 1282734809400385537

linkhttps://medicine.weill.cornell.edu/divisions-programs/infectious-diseases/education/fellowships calendar_today13-07-2020 17:53:12

1,1K Tweet

1,1K Takipçi

586 Takip Edilen

Ndhlovu Lab (@ndhlovulab) 's Twitter Profile Photo

Honored to be part of the 16th edition of "HOT TOPICS in HIV” symposium 2024. Terrific discussion on HIV vaccines, immune recovery, and remission! Thanks to Javier Martínez-Picado and IrsiCaixa AIDS Research Institute for an amazing day!

Honored to be part of the 16th edition of "HOT TOPICS in HIV” symposium 2024. Terrific discussion on HIV vaccines, immune recovery, and remission! Thanks to Javier Martínez-Picado and <a href="/IrsiCaixa/">IrsiCaixa</a> AIDS Research Institute for an amazing day!
IDSA (@idsainfo) 's Twitter Profile Photo

IDSA and PIDS congratulate the 316 adult physicians and 43 pediatric physicians who matched today in infectious diseases! 🎉#WeAreID Learn more: idsociety.org/news--publicat…

IDSA and <a href="/PIDSociety/">PIDS</a> congratulate the 316 adult physicians and 43 pediatric physicians who matched today in infectious diseases! 🎉#WeAreID

Learn more: idsociety.org/news--publicat…
Weill Cornell Medicine (@weillcornell) 's Twitter Profile Photo

A new hepatitis B vaccine is more effective in people living with HIV than an older vaccine type, according to new study from Dr. Kristen Marks of Weill Department of Medicine and Weill Cornell Infectious Diseases Division. Full story: bit.ly/4gcgLDc

A new hepatitis B vaccine is more effective in people living with HIV than an older vaccine type, according to new study from Dr. Kristen Marks of <a href="/WCMDeptofMed/">Weill Department of Medicine</a> and <a href="/WCM_ID/">Weill Cornell Infectious Diseases Division</a>.

Full story: bit.ly/4gcgLDc